Bank Pictet & Cie (Europe)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bank Pictet & Cie (Europe)'s LLY Position: Q2 2026 in Review
Bank Pictet & Cie (Europe) reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $6.81M and leaving 44,977 shares worth $53.9M. The position accounts for 1.05% of the portfolio, ranked #26.
Bank Pictet & Cie (Europe) first reported a position in LLY in Q4 2016 and has held it in 31 quarters since. The position peaked at $64.3M in Q4 2025. 3,051 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bank Pictet & Cie (Europe) held 44,977 shares of Eli Lilly worth $53.9M as of Q2 2026.
- Bank Pictet & Cie (Europe) sold 6,663 Eli Lilly shares in Q2 2026, an estimated $6.81M.
- Eli Lilly made up 1.05% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #26 holding.
- Bank Pictet & Cie (Europe) first reported a position in Eli Lilly in Q4 2016 and has held it in 31 quarters since.
- Bank Pictet & Cie (Europe)'s Eli Lilly position peaked at $64.3M in Q4 2025.
- 3,051 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.